TY  - GEN
AU  - Daniels,G H
AU  - Hegedüs,L
AU  - Marso,S P
AU  - Nauck,M A
AU  - Zinman,B
AU  - Bergenstal,R M
AU  - Mann,J F E
AU  - Derving Karsbøl,J
AU  - Moses,A C
AU  - Buse,J B
AU  - Tuttle,R M
TI  - LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations
SN  - 1463-1326
PY  - 2016///0101
KW  - Aged
KW  - Body Mass Index
KW  - Calcitonin
KW  - blood
KW  - Cardiovascular Diseases
KW  - etiology
KW  - Diabetes Mellitus, Type 2
KW  - Double-Blind Method
KW  - Female
KW  - Glomerular Filtration Rate
KW  - Humans
KW  - Hypoglycemic Agents
KW  - therapeutic use
KW  - Linear Models
KW  - Liraglutide
KW  - adverse effects
KW  - Male
KW  - Middle Aged
KW  - Sex Factors
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/dom.12444
ER  -